openPR Logo
Press release

Stool Secretory Immunoglobulin A [SIgA] Market to Expand with Significant CAGR by 2030

09-09-2021 05:23 AM CET | Health & Medicine

Press release from: Transparency Market Research

Stool Secretory Immunoglobulin A (SIgA) Market: Introduction

According to the report, the global stool secretory immunoglobulin A (SIgA) market was valued at ~US$ 27 Mn in 2019. It is projected to expand at a CAGR of ~3% from 2020 to 2030. Immunological activity in the gastrointestinal tract can be assessed using secretory immunoglobulin A (sIgA). Secretory IgA is the predominant antibody or immune protein; the body manufactures and releases in external secretions such as saliva, tears, and milk. It is also transported through the epithelial cells that line the intestines out into the lumen. Secretory IgA represents the first line of defense of the GI mucosa and is central to the normal function of the GI tract as an immune barrier.

Read Report Overview: https://www.transparencymarketresearch.com/stool-secretory-immunoglobulin-a-siga-market.html

North America dominated the global stool secretory immunoglobulin A (SIgA) market in 2019. The trend is anticipated to continue during the forecast period. Rise in research & development activity in the healthcare industry increases the demand for stool secretory immunoglobulin A (SIgA). This is expected to drive the market in the region.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=80172

Rise in Adoption of Preventative Care for Healthy Lifestyle to Drive Global Market

Fecal secretory IgA (sIgA) is secreted by mucosal tissue and represents the first line of defense of the GI mucosa, and is central to the normal function of the GI tract as an immune barrier. Elevated levels of fecal secretory IgA have been associated with an upregulated immune response. Hence, physician prefer to evaluate the SIgA level in stool before the treatment method they adopt for various infections in the body, and this drives the market for stool secretory immunoglobulin A (SIgA).

Request a Sample of Stool Secretory Immunoglobulin A [SIgA] Market: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=80172

Testing to Dominate Global Market

In terms of use, the global stool secretory immunoglobulin A (SIgA) market has been classified into testing and research. Stool test to check the level of SigA in the body is highly sensitive; therefore, it is often produced defense capability of the body to fight against an infection, and also helps to identify the cause of the disease. Moreover, sIgA is the first line of defense against bacteria, food residues, yeast, parasites, viruses, and imbalances, which may provide the link between gut imbalances and systemic illness. Therefore, doctors prefer to carry out the test to check the immunity of the body. This drives the demand for stool secretory immunoglobulin A (SIgA) in testing purposes. The infection testing segment held a major share of the global market in 2019, owing to high prevalence of infectious diseases such as recurrent ear infection and bronchitis in countries such as the U.S.

Request for Analysis of COVID19 Impact on Stool Secretory Immunoglobulin A [SIgA] Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=80172

Labs and Diagnostic Centers to be Key End User
In terms of end user, the global stool secretory immunoglobulin A (SIgA) market has been divided into hospitals, labs and diagnostics centers, and others. A large number of stool secretory immunoglobulin A tests are performed by standalone and hospital-based diagnostic laboratories in the U.S. Furthermore, the presence of major standalone laboratories, such as Laboratory Corporation of America Holdings (LabCorp) testing a higher volume of patient population in the U.S. and Germany. The higher rate of adoption of new tests and instruments by diagnostic laboratories for secretory immunoglobulin A diagnosis are key factors likely to drive the demand for stool secretory immunoglobulin A in the labs and diagnostic centers segment.

Buy now Stool Secretory Immunoglobulin A [SIgA] Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=80172<ype=S

North America to Dominate Stool Secretory Immunoglobulin A (SIgA) Market

In terms of region, the global stool secretory immunoglobulin A (SIgA) market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global stool secretory immunoglobulin A (SIgA) market in 2019, followed by Europe. North America accounted for a major share of the global stool secretory immunoglobulin A (SIgA) market in 2019, primarily due to significant ongoing research & development activities in clinical R&D to develop new diagnostic tests and expansion of laboratory test portfolio in the region.

Competition Landscape of Stool Secretory Immunoglobulin A (SIgA) Market

The global stool secretory immunoglobulin A (SIgA) market is fragmented in terms of number of players. Key players in the global stool secretory immunoglobulin A (SIgA) market include BioVendor Group, Sigma Diagnostics Inc., American Laboratory Products Company, Calbiotech, Inc., Eagle Biosciences, R-Biopharm AG, and Tecan Trading AG.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.co.uk/news-releases/carbon-therapy-segment-in-particle-therapy-market-to-grow-at-exponential-growth-rate-from-2018-to-2026-tmr-848789727.html

https://www.prnewswire.com/news-releases/strides-in-positive-airway-pressure-devices-market-help-reduce-worldwide-prevalence-of-obstructive-sleep-apnea-valuation-to-rise-at-cagr-of-7-8-from-2019-to-2027-tmr-301136571.html

https://www.prnewswire.com/news-releases/rapid-digitalization-rise-in-awareness-regarding-copd-treatments-to-drive-copd-drug-delivery-devices-market-says-tmr-301356815.html

Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stool Secretory Immunoglobulin A [SIgA] Market to Expand with Significant CAGR by 2030 here

News-ID: 2386926 • Views:

More Releases from Transparency Market Research

Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnostic Advancements, Oral Drug Innovations, and Rising Disease Awareness | TMR
Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnost …
The global Acromegaly Treatment Market is experiencing a significant transformation as improved early diagnosis, innovative therapeutic formulations, and regulatory support converge to expand patient access and drive substantial growth. According to the latest industry analysis, the global market, valued at US$ 1.5 billion in 2024, is projected to reach US$ 3.1 billion by 2035, progressing at a CAGR of 6.7% from 2025 to 2035. Gain a preview of important insights from
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, AI/ML Bioinformatics and Portable DNA Devices Transform Criminal Investigations | TMR
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, A …
The global Forensic Genomics Market is undergoing a period of accelerated transformation and expansion as next-generation sequencing (NGS), advanced PCR workflows, and AI/ML-driven bioinformatics redefine the capabilities of modern forensic investigations. According to the latest industry analysis, the market-valued at US$ 0.5 billion in 2024-is projected to reach approximately US$ 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 14.5% between 2025 and 2035. Access key findings
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for High-Load, High-Precision Actuation Systems Accelerates Worldwide | TMR
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for Hig …
The global Planetary Roller Screw Market is poised for substantial expansion over the next decade, driven by rising demand for high-load, high-precision performance in harsh industrial environments, rapid technological advancements, and the ongoing global shift toward electrified and automated systems. According to the latest industry intelligence, the market-valued at US$ 610.0 Mn in 2024-is projected to reach US$ 1,105.0 Mn by 2035, advancing at a compound annual growth rate (CAGR)
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven by Sustainability Initiatives, Regulatory Compliance, and Rising Industrial Demand
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven b …
The global Chemical Absorbent Cotton Market is entering a phase of sustained expansion, backed by rapid industrialization, strengthened environmental regulations, and growing adoption of biodegradable absorbent solutions across healthcare, chemical handling, automotive, and industrial safety applications. According to the latest industry analysis, the global market-valued at US$ 340.0 million in 2024-is projected to reach US$ 600.1 million by 2035, expanding at a CAGR of 5.4% from 2025 to 2035. Access key

All 5 Releases


More Releases for IgA

IgA Nephropathy Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, IgA Nephropathy pipeline constitutes 25+ key companies continuously working towards developing 30+ IgA Nephropathy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "IgA Nephropathy Pipeline Insight, 2025 [https://www.delveinsight.com/sample-request/iga-nephropathy-igan-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the IgA Nephropathy Market. The IgA Nephropathy Pipeline report
Multiplier Strengthens Identity Governance with Advanced IGA Solutions
Image: https://www.abnewswire.com/upload/2025/08/8c79c8224ecce453d70ad648fa16d5e9.jpg Introduction In today's rapidly evolving digital landscape, managing user identities and access rights has become a critical concern for businesses of all sizes. As organizations expand, ensuring the right individuals have the correct access to systems and data is essential for operational efficiency and security. Multiplier, a leader in innovative enterprise solutions, is empowering companies with comprehensive Identity Governance and Administration (IGA) solutions to address these challenges. IGA Solutions: The Heart
IgA Nephropathy Market Positioned for Accelerated Development Through 2032, Delv …
The Key IgA Nephropathy Companies in the market include - Travere Therapeutics, Asahi Kasei (Calliditas Therapeutics), Vertex Pharmaceuticals, Vera Therapeutics, Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences, Shanghai Alebund Pharmaceuticals, Rohto Pharmaceutical, Wuhan Createrna Science and Technology, Guangdong Hengrui Pharmaceutical, LRx Ionis Pharmaceuticals, Jiangsu HengRui Medicine Co., Ltd., Travere Therapeutics, and others. DelveInsight's "IgA Nephropathy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the IgA Nephropathy,
IgA Nephropathy Market to Reach New Heights in Growth by 2034, DelveInsight Pred …
The Key IgA Nephropathy Companies in the market include - Travere Therapeutics, Asahi Kasei (Calliditas Therapeutics), Vertex Pharmaceuticals, Vera Therapeutics, Visterra, Chinook Therapeutics, Novartis, IgA proteases Selecta Biosciences, Shanghai Alebund Pharmaceuticals, Rohto Pharmaceutical, Wuhan Createrna Science and Technology, Guangdong Hengrui Pharmaceutical, LRx Ionis Pharmaceuticals, Jiangsu HengRui Medicine Co., Ltd., Travere Therapeutics, and others. DelveInsight's "IgA Nephropathy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the IgA Nephropathy,
IgA Nephropathy Drugs Market Trends And Forecast 2023-2030
Innovations and Growth Propel IgA Nephropathy Drugs Market: Global IgA Nephropathy Drugs Market Expands with Technological Advancements and Research Initiatives The IgA nephropathy drugs market is witnessing a surge in product launches driven by advancements in technology and an upswing in research and development activities. IgA nephropathy, an autoimmune disease affecting the kidneys, results in inflammation and kidney damage due to the accumulation of antibody clumps. The market is experiencing notable growth,
IgA Nephropathy Drugs Market Sales, Demands and Forecasts
The IgA Nephropathy Drugs market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with